openPR Logo
Press release

Global Prosthetic Heart Valve Market latest trends and business development strategies by 2024 - top players are Colibri Heart Valve, Corvia Medical Inc., Cardiokinetix, Xeltis, Comed BV, HLT, Inc., Transcatheter Technologies, Neovasc Inc., Sorin Group, M

Global Prosthetic Heart Valve Market

Global Prosthetic Heart Valve Market

Global Prosthetic Heart Valve market research report offers valuable insights and helps client’s gain higher market share into multiple sections impacting the growth of the market globally. For a better understanding of the market, our market experts provide a comprehensive analysis of the factors defining the the growth of the Prosthetic Heart Valve market and encompasses a wide range of factors that will prove crucial to our clients and presents them with actionable insights. The key player analysis of Prosthetic Heart Valve market is intended to provide crucial information and In-depth intelligence on the changing competitive scenarios on market strategies, implemented by the prominent players and the critical products and services offered by them.

The global prosthetic heart valve/ artificial heart valve market accounted to USD 4.53 billion in 2016 growing at a CAGR of 12.70% during the forecast period of 2017 to 2024.

FREE Sample study report is available at http://databridgemarketresearch.com/request-a-sample/?dbmr=global-prosthetic-heart-valve-market

Well known players of global prosthetic heart valve/artificial heart valve market are Abbott, Medtronic, Edwards Lifesciences, Symetis, Boston Scientific, Boston Scientific Cardiology, CryoLife, Inc., Braile Biomédica, Colibri Heart Valve, Abbott, St. Jude Medical, LivaNova, Symetis, Lepu Medical Ltd, Lepu Medical Technology (Beijing) Co., Ltd., Colibri Heart Valve, Corvia Medical Inc., Cardiokinetix, Xeltis, Comed BV, HLT, Inc., Transcatheter Technologies, Neovasc Inc., Sorin Group, Micro Interventional Devices, Inc., Braile Biomedica Industria Comercio E Representacoes, Direct Flow Medical®, Inc., PEROUSE A Vygon company and others.

Competitive Analysis

The global prosthetic heart valve/artificial heart valve market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes prosthetic heart valve/ artificial heart valve market shares for global, Europe, North America, Asia Pacific, and South America.

Market Segmentation

Geographical Segmentation:

• North America
• South America
• Europe
• Asia-Pacific
• Middle East and Africa

On the basis of geography, global prosthetic heart valve/artificial heart valve market report covers data points for 28 countries across multiple geographies such as North America & South America, Europe, Asia-Pacific, and Middle East & Africa. Some of the major countries covered in this report are U.S., Canada, Germany, France, U.K., Netherlands, Switzerland, Turkey, Russia, China, India, South Korea, Japan, Australia, Singapore, Saudi Arabia, South Africa, and Brazil among others. In 2017, North America is expected to dominate the market.

The global prosthetic heart valve/ artificial heart valve market is segmented on the basis of type.

• Type
• Transcatheter Heart Valve
• Tissue Heart Valve
• Mechanical Heart Valve

On the basis of type, global prosthetic heart valve/ artificial heart valve market is segmented into

• transcatheter heart valve,
• tissue heart valve, and
• mechanical heart valve.

Transcatheter heart valves segment is expected to witness the highest market growth in the forecast period (2017-2024) due to use of less invasive techniques, more of technological advancement, increasing number of patients and rising prevalence of aortic stenosis.

FREE TOC is availabe at https://databridgemarketresearch.com/toc/?dbmr=global-prosthetic-heart-valve-market

FACTORS DRIVING GROWTH IN THE GLOBAL PROSTHETIC HEART VALVE MARKET

Increase in the prevalence of heart value disease and valvular heart disease:

The leading of death in U.S. is heart disease, killing more than 600,000 Americans each year. It was found that each year more than 5 million Americans are diagnosed with heart value disease. Heart valve disease can occur in any single valve or a combination of the four valves, but diseases of the aortic and mitral valves are the most common. Calcific aortic stenosis is the most common cause of aortic stenosis. Around 1.5 million people in the United States suffer from aortic stenosis, out of which approximately 500,000 among this group of patients suffer from severe aortic stenosis that is an estimated 250,000 patients with severe aortic stenosis. Around 80,000-85,000 aortic valve replacement procedures are performed every year in the U.S.

Rise in prevalence of cardiac disorders:

According to center for disease control and prevention, coronary heart disease is the most common type of heart disease, killing about 366,000 people in 2015. In the United States, there is a case of heart attack in every 40 seconds. Every minute, more than one person in the United States dies from a heart disease-related event. It was found that heart disease costs the United States around USD 200 billion each year.

Get instant discount at sopan.gedam@databridgemarketresearch.com

About Data Bridge Market Research:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:

Data Bridge Market Research
Tel: +1-888-387-2818
Email: sopan.gedam@databridgemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Prosthetic Heart Valve Market latest trends and business development strategies by 2024 - top players are Colibri Heart Valve, Corvia Medical Inc., Cardiokinetix, Xeltis, Comed BV, HLT, Inc., Transcatheter Technologies, Neovasc Inc., Sorin Group, M here

News-ID: 1233980 • Views:

More Releases from Data Bridge Market Research

Aquaculture Products Market Size, Share, Trends, Key Drivers, Growth Opportuniti …
Aquaculture Products Market business report provides a profound overview of product specification, technology, product type and production analysis considering major factors such as revenue, cost, and gross margin. The data and information collected to generate this top-notch market report has been derived from the trusted sources such as company websites, white papers, journals, and mergers etc. Aquaculture Products Market report includes basic, secondary and advanced information related to the global
Hydrochloric Acid Market Size, Share, Trends, Demand, Future Growth, Challenges …
Data Bridge Market research has recently released expansive research titled Global Hydrochloric Acid Market  guarantees you will remain better informed than your competition.The report is formulated based on the market type, organization size, availability on-premises, the end-users' organization type, and the availability in areas such as North America, South America, Europe, Asia-Pacific and Middle East & Africa. Businesses can accomplish knowledge about complete background analysis of the industry which includes
Electrostatic Disinfectant Sprayer Market Size, Share, Demand, Future Growth, Ch …
Global Electrostatic Disinfectant Sprayer Market report puts light on analysis of prime manufacturers, trends, opportunities, marketing strategies analysis, market effect factor analysis and consumer needs by major regions, types, and applications globally. The study offers a comprehensive analysis of the key market dynamics and their latest trends, along with pertinent market segments and sub-segments. The data and information covered in the Electrostatic Disinfectant Sprayer report are obtained from reliable sources
Paint Protection Film Market Size, Share, Trends, Opportunities, Key Drivers and …
Global Paint Protection Film Market study by Data Bridge Market Research provides details about the market dynamics affecting this market, Market scope, Market segmentation and overlays shadow upon the leading market players highlighting the favourable competitive landscape and trends prevailing over the years. The latest market data has been presented in the Paint Protection Film market study on the revenue numbers, product details, and sales of the major firms. In addition

All 5 Releases


More Releases for Heart

Heart disease and Heart Attacks - Kaffailham.gr
Καρδιολόγος Αθηνα - https://kaffailham.gr When people talk about heart disease or heart attacks. The arteries that they are talking about are the arteries that actually provide blood to the heart. Remember the heart itself is a muscle. It itself needs oxygen. So you have these arteries right over here, the red tubes. Those are arteries. and then the blue ones are veins. They're taking the de-oxygenated blood away from the tissue
Artificial Heart Implant Market May See a Big Move | Major Giants Jarvik Heart, …
The Latest survey report on Artificial Heart Implant Market sheds lights on changing dynamics of each of the subsegments of Industry. As the shift to value continues, Artificial Heart Implant organizations have the dual challenge of increasing interoperability to improve clinical performance and the patient experience. Some of the companies listed in the study from complete survey list are Medtronic, Boston Scientific, Abbott, Terumo, B.Braun, SynCardia, BiVACOR, CARMAT, ReinHeart TAH
Heart Pump Device Market - Potential Innovations 2025 | Terumo, Jarvik Heart
Heart Pump Device Market: Snapshot Heart pump devices are essentially mechanical pumps playing the role of ventricular assist devices. These are surgically implanted and are used for temporarily supporting the functions of heart in people with weak heart or irregular blood flow. These devices are notably used as a bridge to cardiac transplantation for patients suffering with end stage heart failure. They can also be used in patients during and after
Congestive Heart Failure (Heart Failure)-Pipeline Review, H2 2017
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Congestive Heart Failure (Heart Failure)-Pipeline Review, H2 2017, provides an overview of the Congestive Heart Failure (Heart Failure) (Cardiovascular) pipeline landscape. Heart failure is also known as congestive heart failure (CHF). CHF is a condition in which the heart is no longer able to pump out enough oxygen-rich blood. Symptoms include cough, fatigue, weakness, faintness, loss of appetite, swollen (enlarged) liver
Congestive Heart Failure (Heart Failure) - Pipeline Review, H2 2017
ReportsWorldwide has announced the addition of a new report title Congestive Heart Failure (Heart Failure) - Pipeline Review, H2 2017 to its growing collection of premium market research reports. Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Congestive Heart Failure (Heart Failure) - Pipeline Review, H2 2017, provides an overview of the Congestive Heart Failure (Heart Failure) (Cardiovascular) pipeline landscape. Heart failure is also known as congestive heart failure (CHF).
Congestive Heart Failure (Heart Failure) Market Research Report
Latest industry research report on: Congestive Heart Failure (Heart Failure) Market | Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts GlobalData's clinical trial report, Congestive Heart Failure (Heart Failure) Global Clinical Trials Review, H1, 2017" provides an overview of Congestive Heart Failure (Heart Failure) clinical trials scenario. This report provides top line data relating to the clinical trials on Congestive Heart Failure (Heart Failure). Report includes an